SMN2 and spinal muscular atrophy, type 1: This observation supports the recent opinion that an improvement up to and above 40 points is very uncommon in SMA type I infants with 2 copies of SMN2 and would indicate a favorable treatment effect beyond what has been observed in untreated patients.